Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone
This paper reports data on the bone, specifically the tibia and mandible, of nonobese diabetic mice with severe combined immunodeficiency disease (NOD–SCID mice) treated with zoledronic acid (ZA) and prednisolone (PSL). The data described here are related to the research article titled “Zoledronic a...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-06-01
|
| Series: | Data in Brief |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340916302554 |
| _version_ | 1818127970576891904 |
|---|---|
| author | Naoko Hori Takahiro Abe Tsuyoshi Sato Shoichiro Kokabu Yumiko Shimamura Tomoya Sato Tetsuya Yoda |
| author_facet | Naoko Hori Takahiro Abe Tsuyoshi Sato Shoichiro Kokabu Yumiko Shimamura Tomoya Sato Tetsuya Yoda |
| author_sort | Naoko Hori |
| collection | DOAJ |
| description | This paper reports data on the bone, specifically the tibia and mandible, of nonobese diabetic mice with severe combined immunodeficiency disease (NOD–SCID mice) treated with zoledronic acid (ZA) and prednisolone (PSL). The data described here are related to the research article titled “Zoledronic acid basically increases circulating soluble RANKL level in mice, and in glucocorticoid-administrated mice, more increases lymphocytes derived sRANKL by bacterial endotoxic stimuli” [1]. The present data and the NOD–SCID mice experiments described contain insights into the role of bone-remodeling factors induced by ZA treatment. Keywords: Zoledronic acid, NOD–SCID mice, Medication-related osteonecrosis of the jaw |
| first_indexed | 2024-12-11T07:25:49Z |
| format | Article |
| id | doaj.art-cb4482f4e72749398d622e3232d6e77f |
| institution | Directory Open Access Journal |
| issn | 2352-3409 |
| language | English |
| last_indexed | 2024-12-11T07:25:49Z |
| publishDate | 2016-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Data in Brief |
| spelling | doaj.art-cb4482f4e72749398d622e3232d6e77f2022-12-22T01:15:58ZengElsevierData in Brief2352-34092016-06-01714861490Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisoloneNaoko Hori0Takahiro Abe1Tsuyoshi Sato2Shoichiro Kokabu3Yumiko Shimamura4Tomoya Sato5Tetsuya Yoda6Department of Oral and Maxillofacial Surgery, JapanDepartment of Oral and Maxillofacial Surgery, Japan; Department of Oral and Maxillofacial Surgery, The University of Tokyo, Japan; Correspondence to: Department of Oral and Maxillofacial Surgery, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. Tel.: +81 3 5800 8669; fax: +81 3 5800 6832.Department of Oral and Maxillofacial Surgery, JapanDepartment of Molecular Signaling & Biochemistry, Kyushu Dental College, JapanDepartment of Oral and Maxillofacial Surgery, JapanDepartment of Plastic and Reconstructive Surgery, Faculty of Medicine, Saitama Medical University, JapanDepartment of Oral and Maxillofacial Surgery, JapanThis paper reports data on the bone, specifically the tibia and mandible, of nonobese diabetic mice with severe combined immunodeficiency disease (NOD–SCID mice) treated with zoledronic acid (ZA) and prednisolone (PSL). The data described here are related to the research article titled “Zoledronic acid basically increases circulating soluble RANKL level in mice, and in glucocorticoid-administrated mice, more increases lymphocytes derived sRANKL by bacterial endotoxic stimuli” [1]. The present data and the NOD–SCID mice experiments described contain insights into the role of bone-remodeling factors induced by ZA treatment. Keywords: Zoledronic acid, NOD–SCID mice, Medication-related osteonecrosis of the jawhttp://www.sciencedirect.com/science/article/pii/S2352340916302554 |
| spellingShingle | Naoko Hori Takahiro Abe Tsuyoshi Sato Shoichiro Kokabu Yumiko Shimamura Tomoya Sato Tetsuya Yoda Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone Data in Brief |
| title | Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone |
| title_full | Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone |
| title_fullStr | Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone |
| title_full_unstemmed | Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone |
| title_short | Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone |
| title_sort | data in support of the bone analysis of nod scid mice treated with zoledronic acid and prednisolone |
| url | http://www.sciencedirect.com/science/article/pii/S2352340916302554 |
| work_keys_str_mv | AT naokohori datainsupportoftheboneanalysisofnodscidmicetreatedwithzoledronicacidandprednisolone AT takahiroabe datainsupportoftheboneanalysisofnodscidmicetreatedwithzoledronicacidandprednisolone AT tsuyoshisato datainsupportoftheboneanalysisofnodscidmicetreatedwithzoledronicacidandprednisolone AT shoichirokokabu datainsupportoftheboneanalysisofnodscidmicetreatedwithzoledronicacidandprednisolone AT yumikoshimamura datainsupportoftheboneanalysisofnodscidmicetreatedwithzoledronicacidandprednisolone AT tomoyasato datainsupportoftheboneanalysisofnodscidmicetreatedwithzoledronicacidandprednisolone AT tetsuyayoda datainsupportoftheboneanalysisofnodscidmicetreatedwithzoledronicacidandprednisolone |